Vemurafenib for BRAF V600-mutant Erdheim-Chester disease presenting with bilateral orbital involvement.

Wang, Xiaomeng; Cao, Jie; Du, Weijiao; Ma, Wenchao; Meng, Bin; Cao, Shui

Wang, Xiaomeng; Cao, Jie; Du, Weijiao; Ma, Wenchao; Meng, Bin; Cao, Shui.

Afiliación

Wang X; Tianjin Medical University Cancer Institute and Hospital Tianjin China.
Cao J; Cancer Immunotherapy Department Tianjin Cancer Hospital Airport Hospital Tianjin China.
Du W; National Clinical Research Center for Cancer Tianjin China.
Ma W; Tianjin's Clinical Research Center for Cancer Tianjin China.
Meng B; Key Laboratory of Cancer Prevention and Therapy Tianjin China.
Cao S; Tianjin Medical University Cancer Institute and Hospital Tianjin China.

Clin Case Rep ; 11(8): e7780, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37609641

Palabras clave

BRAFV600E mutation; ErdheimChester disease; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Case Rep Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google